Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Questions over ghostwriting in drug industry

Nature (2010)Cite this article

Subjects

Analysis claims papers drafted by medical writers downplayed risks of hormone replacement therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fugh-Berman, A. J. PLoS Medicine 7, e1000335 (2010).

    Article  Google Scholar 

  2. Writing Group for the Women's Health Initiative Investigators. J. Am. Med. Assoc. 288, 321-333 (2002).

    Article  Google Scholar 

Download references

Authors
  1. Ewen Callaway
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Wyeth's ghostwriting skeletons yanked from the closet

Judge orders Wyeth to open up

Related external links

Adriane Fugh-Berman

Thomas Stossel

Leemon McHenry

HRT documents

Rights and permissions

Reprints and permissions

About this article

Cite this article

Callaway, E. Questions over ghostwriting in drug industry. Nature (2010). https://doi.org/10.1038/news.2010.453

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2010.453

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing